related documents
- Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA. 5 phase III randomized clinical trial Conferences
- Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA.5 phase III randomized clinical trial Conferences